BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11201378)

  • 21. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
    Ornstein DL; Nervi AM; Rigas JR
    Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
    d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):352-63. PubMed ID: 17258563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG).
    Kotsakis A; Kentepozidis N; Emmanouilidis Ch; Polyzos A; Agelidou A; Vaslamatzis M; Chandrinos V; Agelaki S; Vamvakas L; Kalbakis K; Katsaounis P; Stoltidis D; Nintos G; Hatzidaki D; Vetsika EK; Mavroudis D; Georgoulias V
    Lung Cancer; 2015 Apr; 88(1):57-62. PubMed ID: 25662596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
    Rigas JR
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Two cases of complete response to combination chemotherapy of gemcitabine and docetaxel for recurrent ovarian cancer].
    Ito K; Adachi S; Iijima T; Nakatsuji Y; Kimura T; Nobunaga T
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):141-4. PubMed ID: 12557720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gemcitabine].
    Takeda K
    Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenging the platinum combinations in the chemotherapy of NSCLC.
    Douillard JY; Eckardt J; Scagliotti GV
    Lung Cancer; 2002 Dec; 38 Suppl 4():21-8. PubMed ID: 12480191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
    Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives and opportunities: Docetaxel in the current and future treatment of non-small cell lung cancer.
    Green MR
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):17-21. PubMed ID: 12170447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.
    Georgoulias V; Scagliotti G; Miller V; Eckardt J; Douillard JY; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):15-21. PubMed ID: 11284620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Refractory non-small-cell lung cancer responding to combination chemotherapy with gemcitabine and cisplatin].
    Miyazawa M; Hyougotani A; Koyama H; Haba T; Katoh K; Muramatsu A; Ozawa K
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1227-30. PubMed ID: 12146004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.
    Pectasides D; Aspropotamitis A; Halikia A; Visvikis A; Antoniou F; Kalantaridou A; Karvounis N; Batzios S; Athanassiou A
    J Clin Oncol; 1999 Dec; 17(12):3816-21. PubMed ID: 10577854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.
    Pouessel D; Culine S; Becht C; Romieu G; Fabbro M; Ychou M; Cupissol D; Pinguet F
    Anticancer Res; 2003; 23(3C):2801-4. PubMed ID: 12926116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Nihon Rinsho; 2002 May; 60 Suppl 5():591-5. PubMed ID: 12101743
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
    Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K
    Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["State-of-the-art" chemotherapy for small-cell lung cancer].
    Negoro S
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():398-404. PubMed ID: 9369914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
    Grigorescu AC; Draghici IN; Nitipir C; Gutulescu N; Corlan E
    Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
    Ito T; Mochida A; Saito K; Nishi K; Sasaki S; Hisada T; Morinari H; Nakahara K; Tahara M; Masuda S; Yakumaru K
    Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):71-6. PubMed ID: 11925923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of recurrence and systemic metastasis of oral cancer successfully treated with combination chemotherapy of cisplatin and gemcitabine].
    Minami S; Komut K
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):215-7. PubMed ID: 15751635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.